ISRCTN61961630已完成不适用
A Randomised Study of continuous infusion 5-Fluorouracil (5FU) with or without bolus Mitomycin-C in Patients with Advanced Pancreatic Cancer
The Royal Marsden NHS Foundation Trust (UK)0 个研究点目标入组 208 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 208
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Histological evidence of locally advanced or metastatic carcinoma of the pancreas not amenable to surgery or radiotherapy. Alternatively patients would have radiologically measurable evidence of locally advanced or metastatic carcinoma of the pancreas not amenable to surgery or radiotherapy, without histological evidence but with a carcinoembryonic antigen (CEA) above 50.
排除标准
- •Does not match inclusion criteria
研究者
相似试验
已完成
不适用
A randomised study of continuous infusional 5-fluorouracil (5FU) with or without bolus mitomycin-C in patients with advanced oesophago-gastric cancerAdvanced oesophago-gastric cancerMalignant neoplasm of stomachCancerISRCTN43866427The Royal Marsden NHS Foundation Trust (UK)254
已完成
不适用
A randomised study of continuous infusional 5-fluorouracil with or without bolus mitomycin-C in patients with advanced colorectal cancerColon, Rectal cancerMalignant neoplasm of other and ill-defined digestive organsCancerISRCTN27478455The Royal Marsden NHS Foundation Trust (UK)200
已完成
不适用
A randomised study of continuous infusional 5-Fluorouracil (5FU) with or without bolus mitomycin-C in patients with carcinoma of unknown primary origiCarcinoma of unknown primary originMalignant neoplasm without specification of siteCancerISRCTN63374575The Royal Marsden NHS Foundation Trust (UK)88
已完成
不适用
A randomised study of continuous infusional 5-Fluorouracil (5FU) with or without mitomycin-C in patients with neuroendocrine tumourseuroendocrine tumoursMalignant neoplasm of other endocrine glands and related structuresCancerISRCTN53478221The Royal Marsden NHS Foundation Trust (UK)
进行中（未招募）
不适用
Phase I/II study of continous infusion with 5-FU and weekly Oxaliplatin / Cetuximab combined with concurrent radiation as neoadjuvant treatment in locally advanced oesophageal squamous cell carcinoma.EUCTR2006-001097-24-DETechnische Universitaet Muenchen, Medizinische Fakultaet